Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy

Author:

Cento ValeriaORCID,Alteri Claudia,Merli MarcoORCID,Di Ruscio Federica,Tartaglione Livia,Rossotti Roberto,Travi GiovannaORCID,Vecchi Marta,Raimondi Alessandro,Nava Alice,Colagrossi Luna,Fumagalli Roberto,Ughi Nicola,Epis Oscar Massimiliano,Fanti Diana,Beretta Andrea,Galbiati Filippo,Scaglione Francesco,Vismara Chiara,Puoti Massimo,Campisi Daniela,Perno Carlo Federico

Abstract

Objective Through a hospital-based SARS-CoV-2 molecular and serological screening, we evaluated the effectiveness of two months of lockdown and two of surveillance, in Milan, Lombardy, the first to be overwhelmed by COVID-19 pandemics during March-April 2020. Methods All subjects presenting at the major hospital of Milan from May-11 to July-5, 2020, underwent a serological screening by chemiluminescent assays. Those admitted were further tested by RT-PCR. Results The cumulative anti-N IgG seroprevalence in the 2753 subjects analyzed was of 5.1% (95%CI = 4.3%-6.0%), with a peak of 8.4% (6.1%-11.4%) 60–63 days since the peak of diagnoses (March-20). 31/106 (29.2%) anti-N reactive subjects had anti-S1/S2 titers >80 AU/mL. Being tested from May-18 to June-5, or residing in the provinces with higher SARS-CoV-2 circulation, were positively and independently associated with anti-N IgG reactivity (OR [95%CI]: 2.179[1.455–3.264] and 3.127[1.18–8.29], respectively). In the 18 RT-PCR positive, symptomatic subjects, anti-N seroprevalence was 33.3% (95% CI: 14.8%-56.3%). Conclusion SARS-CoV-2 seroprevalence in Milan is low, and in a downward trend after only 60–63 days since the peak of diagnoses. Italian confinement measures were effective, but the risk of contagion remains concrete. In hospital-settings, the performance of molecular and serological screenings upon admission remains highly advisable.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. World Health Organization. WHO statement on the novel coronavirus 2020 [January 30, 2020]. Available from: https://www.who.int/ihr/procedures/novel-coronavirus-2019/en/.

2. Ministero della Salute. COVID-19—Situazione in Italia 2020. Available from: http://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bce2cce478eaac82fe38d4138b1. Last accessed 07/10/2020.

3. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo';E Lavezzo;Nature,2020

4. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study;M Pollan;Lancet,2020

5. Spread of SARS-CoV-2 in the Icelandic Population;DF Gudbjartsson;The New England journal of medicine,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3